EMEA-001006-PIP03-16 - paediatric investigation plan
nintedanib
PIPHuman
Boehringer Ingelheim International GmbH
Tel. +49 6132 778271
Email: Paediatrics@boehringer-ingelheim.com
P/0124/2017: EMA decision of 5 May 2017 on the granting of a product-specific waiver for nintedanib (Vargatef, Ofev), (EMEA-001006-PIP03-16)